Common Stock, Shares, Outstanding of Eton Pharmaceuticals, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Eton Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Eton Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 26,817,535, a 3.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Eton Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 26,817,535 +981,331 +3.8% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 26,817,535 +1,071,733 +4.2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 26,817,535 +1,126,973 +4.4% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 26,709,084 +1,021,022 +4% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 25,836,204 +177,808 +0.69% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 25,745,802 +183,808 +0.72% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 25,690,562 +186,184 +0.73% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 25,688,062 +334,943 +1.3% 31 Dec 2023 10-Q 06 Nov 2025 2025 Q3
Q3 2023 25,658,396 +361,359 +1.4% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 25,561,994 +289,957 +1.1% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 25,504,378 +878,374 +3.6% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 25,353,119 +727,115 +3% 31 Dec 2022 10-Q 06 Nov 2025 2025 Q3
Q3 2022 25,297,037 +690,862 +2.8% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 25,272,037 +671,862 +2.7% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 24,626,004 +143,388 +0.59% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 24,626,004 +313,196 +1.3% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 24,606,175 +3,617,642 +17% 30 Sep 2021 10-Q 16 Nov 2021 2021 Q3
Q2 2021 24,600,175 +3,644,142 +17% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 24,482,616 +3,720,656 +18% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 24,312,808 +6,435,322 +36% 31 Dec 2020 10-K 14 Mar 2024 2023 FY
Q3 2020 20,988,533 +3,181,366 +18% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 20,956,033 +3,192,988 +18% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 20,761,960 +3,134,032 +18% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 17,877,486 +269,558 +1.5% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 17,807,167 +11,588,187 +186% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 17,763,045 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 17,627,928 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 17,607,928 +11,607,928 +193% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 6,218,980 30 Sep 2018 10-Q 20 Dec 2018 2018 Q3
Q4 2017 6,000,000 31 Dec 2017 10-K 25 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.